| Authors: |
Winthrop HM; Duke Office of Clinical Research, Duke University School of Medicine, Durham, North Carolina. Electronic address: hilary.winthrop@duke.edu., Li Y; Duke Cancer Institute Biostatistics Shared Resource, Duke University, Durham, North Carolina., Underwood D; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Hill L; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Racioppi A; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Lee R; Division of Endocrinology and Metabolism, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Messina JA; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Lowder Y; Duke Office of Clinical Research, Duke University School of Medicine, Durham, North Carolina., Alyea EP; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Hong S; Department of Population Health Sciences, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Lin C; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Sung AD; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas. |
